EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)

(MedPage Today) -- Ertugliflozin improved T2D control atop metformin/sitagliptin

Source: MedPage Today Nephrology - September 15, 2016 Category: Urology & Nephrology Source Type: news